A system for treating open wounds includes a foam material configured for pouring, spraying, injecting or spreading on a wound bed. The foam material can comprise a base component and a curing component, which can be pre-mixed before application, or mixed in situ as the components are being applied to the wound site. A third component can comprise a sacrificial porogen. Foam can be placed in the wound bed as a wound liner on the wound surfaces. An additional foam insulation can provide a foam filler partially contained by the wound liner and generally flush with a patient's epidermis. A method of treating open wounds includes the steps of applying the wound liner and filler components. An optional step comprises covering the wound liner with a semi-permeable (breathable) membrane and mounting inlet and outlet ports thereon for introducing healing compositions as input, and extracting wound exudates as output.

Tattoo protector bandage and use as a tattoo protector of the type having a tubular configuration, having at least one opening for introducing a member of the human body and defining an inner side which is in contact with the skin, and an outer side; characterised in that it comprises, out of the total: 90-94% viscose, 4-6% elastane and 2-4% polyamide.

A wound sealing powder, method of making a wound sealing powder, and method of using a wound sealing powder to reduce blood flow from a wound are provided. Specifically, the wound sealing powder utilizes a particulate powder material of an effective amount of an insoluble cation exchange material wherein the majority of the particles in the powder have particle sizes of less than approximately 48 microns.

Wound cleaning device having a carrier layer and a wound cleaning layer arranged thereon, designed for holding wound exudate and/or solid wound components and having cleaning threads, the carrier layer and/or the wound cleaning layer being provided with at least one storage material that increases the capacity for holding wound exudate.

Wound therapy dressings are provided. The wound therapy dressings may include at least one selectively transparent layer with a refractive index in a range wherein interaction between the selectively transparent layer and fluids from a treatment site switches the selectively transparent layer from a first, opaque state to a second, transparent state. Dressings that include multiple layers may include polymer films with a plurality of fluid restrictions, a manifold, a transparent polymer drape, and a hydrophobic polymer layer. The dressings may further include negative pressure therapy treatment input devices. A method of use wherein the dressings are used to monitor fluid flow, exudate, and maceration around a treatment site is also provided.

The disclosure is directed to fibrous structures finished with active pharmaceutical ingredients, as well as methods of their manufacturer and use.

A fluid containment layer adapted to be used in a pad for absorption, containment, and/or controlled release of liquid or gel, where the fluid containment layer absorbs and/or holds a liquid or gel, such as a disinfecting liquid or gel. The fluid containment layer is resilient and returns to its original shape upon pressure applied thereto. The fluid containment layer includes generally vertically oriented fibers. The fluid containment layer may be used in a self-disinfecting pad.

Embodiments disclosed herein are directed to negative pressure treatment systems and wound dressing systems, apparatuses, and methods that may be used for the treatment of wounds. In particular, some embodiments are directed to improved wound dressings comprising a number of viewing portals that facilitate observation of wound tissue or healthy skin underlying the wound dressing. Some embodiments of the viewing portals are provided by forming through holes in internal dressing layers including absorbent material and transmission material, optionally by providing a plug material within the through holes, and by providing translucent or transparent cover layer and tissue contact layer materials.

Disclosed herein are improved methods and apparatuses for providing hemostasis within a cavity defined by an internal surface of a bleeding tissue space. A catheter comprising a proximal end and a distal end may be advanced into the cavity through a proximal opening of the tissue space into the cavity. A distal balloon coupled to the catheter may be positioned adjacent a distal opening of the tissue space, and expanded to seal the distal opening. A hemostatic agent may be applied from the catheter to the internal surface of the tissue space to inhibit bleeding of the tissue space. The hemostatic agent may be applied without occluding the proximal opening, the distal opening, and a path extending therebetween with the hemostatic agent.

A penile condom catheter facilitates urine collection and egress of urinary fluids away from the body torso. A circumferential anchoring structure includes a web of flexible strands sized and arranged to at least partially contact a portion of the penis. The anchoring structure provides a flexible yet secure hold against the penis when flaccid and provides an increase in the hold when a longitudinal force is exerted upon the anchoring structure. An annularly circumferential penile skin covering material is affixed to the anchoring structure and sized to fit over at least a portion of the penis. A seal is affixed to at least a portion of a covering material, a covering material orifice, or an anchoring structure. A conduit is affixed to at least one of a covering material, a covering material orifice, a seal and an anchoring structure created to permit the flow of urinary fluid away.